| Literature DB >> 35664750 |
Da-Wei Zhao1,2,3, Xue-Mei Fang3,4, Shu-Han Zhou5, Yan-Rong Luo3, Jian Wei6, Kun Liu6, Ling-Ling Meng3, Gang Liu7, Jin-Feng Li7, Xiao Zang7, Meng Li7, Xiao-Fei Qiang7,8, Hua-Yong Jiang7,9, Wen-Jun Fan10,11, Xin-Xin Zhang6, Lin Ma3,9.
Abstract
Purpose: The aim of this study was to identify the efficacy of diffusion kurtosis imaging (DKI) in tracking and monitoring the dynamic change of parotid glands (PGs), submandibular glands (SMGs), sublingual glands (SLGs), and acute xerostomia in nasopharyngeal carcinoma (NPC) patients treated with induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT).Entities:
Keywords: diffusion kurtosis imaging; parotid gland; radiation; sublingual gland; submandibular gland; xerostomia
Year: 2022 PMID: 35664750 PMCID: PMC9162117 DOI: 10.3389/fonc.2022.870315
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1Illustrations of the region of interest of the right parotid gland (PG), sublingual gland (SLG), and submandibular gland (SMG) (yellow solid arrow). DKI, diffusion kurtosis imaging; MD, mean diffusion; MK, mean kurtosis.
Demographic and clinical characteristics of patients.
| Characteristics | Value |
|---|---|
| 43.19 ± 12.12 | |
| Male | 33 (78.6%) |
| Female | 9 (21.4%) |
| T1 | 2 (4.8%) |
| T2 | 22 (50.4%) |
| T3 | 13 (30.9%) |
| T4 | 5 (11.9%) |
| N0 | 1 (2.4%) |
| N1 | 7 (16.7%) |
| N2 | 18 (42.8%) |
| N3 | 16 (38.1%) |
| Non-cornification undifferentiated | 21 (50%) |
| Low differentiated | 17 (40.5%) |
| Moderately differentiated | 4 (9.5%) |
| PG-R | 32.58 Gy (26.06–41.44) |
| PG-L | 33.01 Gy (27.34–42.56) |
| SMG-R | 50.20 Gy (22.82–64.77) |
| SMG-L | 47.89 Gy (25.46–66.45) |
| SLG-R | 31.35 Gy (17.46–57.66) |
| SLG-L | 28.39 Gy (17.17–45.81) |
PG-R, right parotid gland; PG-L, left parotid gland; SMG-R, right submandibular gland; SMG-L, left submandibular gland; SLG-R, right sublingual gland; SLG-L, left sublingual gland. AJCC 8th edition (AJCC-8th) staging system was used to determine patients’ AJCC stage.
MD and MK of bilateral PGs, SMGs, and SLGs with uSFR, sSFR, and XQ scores at each time point.
| MD (m ± sd) | MK (m ± sd) | SFR (m ± sd) | XQ | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PG | SMG | SLG | PG | SMG | SLG | uSFR | sSFR | ||||||||||
| R | L | R | L | R | L | R | L | R | L | R | L | ||||||
| 1.07 ± 0.22bc | 1.06 ± 0.22bc | 1.37 ± 0.23 | 1.34 ± 0.21 | 1.33 ± 0.23 | 1.33 ± 0.24 | 1.03 ± 0.15bc | 1.03 ± 0.21bc | 0.76 ± 0.09 | 0.74 ± 0.12 | 0.73 ± 0.12 | 0.71 ± 0.17 | 1.53 ± 2.24e | 3.76 ± 2.73 | 4.55 ± 3.48 | |||
| 1.11 ± 0.22bc | 1.09 ± 0.24bc | 1.54 ± 0.24 | 1.50 ± 0.21 | 1.46 ± 0.26 | 1.42 ± 0.26 | 0.99 ± 0.16bc | 1.04 ± 0.20bc | 0.71 ± 0.07 | 0.70 ± 0.06 | 0.69 ± 0.10 | 0.67 ± 0.12 | 1.48 ± 1.41e | 3.12 ± 2.41 | 5.21 ± 3.65 | |||
| 1.38 ± 0.31c | 1.38 ± 0.31bc | 1.70 ± 0.31d | 1.65 ± 0.26d | 1.57 ± 0.29 | 1.55 ± 0.29 | 0.90 ± 0.18bc | 0.90 ± 0.18bc | 0.67 ± 0.10 | 0.66 ± 0.09 | 0.66 ± 0.17 | 0.65 ± 0.18 | 0.55 ± 0.58e | 1.16 ± 1.37 | 16.31 ± 4.14 | |||
| 1.56 ± 0.32c | 1.55 ± 0.33b | 1.94 ± 0.33d | 1.89 ± 0.30d | 1.74 ± 0.27 | 1.68 ± 0.30 | 0.83 ± 0.17bc | 0.82 ± 0.17bc | 0.60 ± 0.06d | 0.59 ± 0.06d | 0.56 ± 0.09 | 0.55 ± 0.07 | 0.22 ± 0.42e | 0.49 ± 0.72 | 18.60 ± 3.91 | |||
| 1.66 ± 0.26bc | 1.63 ± 0.28c | 1.99 ± 0.28a | 1.93 ± 0.29 | 1.80 ± 0.26 | 1.73 ± 0.30 | 0.75 ± 0.15abc | 0.77 ± 0.15bc | 0.59 ± 0.08d | 0.60 ± 0.08d | 0.56 ± 0.08 | 0.56 ± 0.08 | 0.12 ± 0.25e | 0.28 ± 0.41 | 17.12 ± 5.64 | |||
| 1.70 ± 0.26bc | 1.68 ± 0.24b | 2.05 ± 0.24d | 1.99 ± 0.32d | 1.85 ± 0.27a | 1.75 ± 0.34 | 0.74 ± 0.14bc | 0.74 ± 0.14bc | 0.57 ± 0.06 | 0.57 ± 0.07 | 0.58 ± 0.10 | 0.57 ± 0.10 | 0.07 ± 0.11e | 0.17 ± 0.17 | 16.60 ± 5.15 | |||
MD, mean diffusion; MK, mean kurtosis. PG, parotid gland; SMG, submandibular gland; SLG, sublingual gland; R, right; L, left; t1, prior to induction chemotherapy; t2, before radiotherapy; t3, middle of radiotherapy; t4, immediately after radiotherapy; t5, 1 month after radiotherapy; t6, 3 months after radiotherapy. adenotes a significant difference between the left and right salivary glands. bdenotes a significant difference between ipsilateral PG and SMG. cdenotes a significant difference between ipsilateral PG and SLG. ddenotes a significant difference between ipsilateral SMG and SLG. edenotes a significant difference between uSFR and sSFR.
Figure 2(A) denotes comparisons of MD between the left and the right side of the major salivary glands, and between ipsilateral PG, SMG, and SLG; (B) denotes comparisons of MK between the left and the right side of the major salivary glands, and between ipsilateral PG, SMG, and SLG. Abbreviations are referred to in .
Figure 3The comparisons of uSFR and sSFR at pre-IC, pre-RT, mid-RT, post-RT, 1m-RT, and 3m-RT denote that sSFR was significantly higher than uSFR at each time point. Abbreviations are referred to in .
Figure 4(A–I) The pairwise comparisons of MD and MK of left PG, SMG, SLG, and uSFR, sSFR, and XQ between different time points; p < 0.05 denotes significant differences between two time points linked together. Abbreviations are referred to in .
Figure 5Scatter dot plots of the change ratio of MD and MK versus dose of bilateral PGs, SMGs, and SLGs. Abbreviations are referred to in .
Correlation analysis of the change ratio of the DKI metrics of the salivary glands from pre-RT to post-RT with the dose of ipsilateral salivary glands.
| ΔMD-PG-R% | 0.605 | |
| ΔMK-PG-R% | 0.616 | |
| ΔMD-PG-L% | 0.714 | |
| ΔMK-PG-L% | 0.349 | |
| ΔMD-SMG-R% | 0.401 | |
| ΔMK-SMG-R% | 0.378 | |
| ΔMD-SMG-L% | 0.596 | |
| ΔMK-SMG-L% | 0.665 | |
| ΔMD-SLG-R% | 0.485 | |
| ΔMK-SLG-R% | 0.096 | 0.544 |
| ΔMD-SLG-L% | 0.256 | 0.097 |
| ΔMK-SLG-L% | 0.126 | 0.425 |
r represents correlation coefficients. The correlation analysis was conducted between the change ratio of the DKI parameters (MD and MK) from pre-RT to post-RT with the dose of ipsilateral salivary glands. The bold values represent p<0.05. Abbreviations are referred to in .
Figure 6(A) Heatmap of the correlation coefficients between the change ratio of DKI metrics (MD and MK) from pre-RT to post-RT and dose of bilateral salivary glands. (B) Heatmap of the correlation coefficients between the change ratio of DKI metrics (MD and MK) of the salivary glands and the change ratio of uSFR, sSFR, and XQ scores from pre-RT to post-RT. Abbreviations are referred to in .
Correlation analysis of the change ratio of the DKI metrics with the change ratio of uSFR, sSFR, and XQ scores from pre-RT to post-RT.
| ΔuSFR%, | ΔsSFR%, | ΔXQ%, | |
|---|---|---|---|
| ΔMD-PG% | −0.180 (0.253) | 0.253 (0.106) | |
| ΔMD-SMG% | |||
| ΔMD-SLG% | −0.09 (0.547) | 0.137 (0.386) | |
| ΔMK-PG% | 0.105 (0.469) | ||
| ΔMK-SMG% | 0.219 (0.163) | −0.192 (0.223) | |
| ΔMK-SLG% | 0.167 (0.290) | 0.017 (0.913) | −0.058 (0.713) |
r represents correlation coefficient. The bold values represent p<0.05.